174 related articles for article (PubMed ID: 28776376)
1. New Evidence for the Mechanism of Action of a Type-2 Diabetes Drug Using a Magnetic Bead-Based Automated Biosensing Platform.
Uddin R; Nur-E-Habiba ; Rena G; Hwu ET; Boisen A
ACS Sens; 2017 Sep; 2(9):1329-1336. PubMed ID: 28776376
[TBL] [Abstract][Full Text] [Related]
2. Biomolecular mode of action of metformin in relation to its copper binding properties.
Repiščák P; Erhardt S; Rena G; Paterson MJ
Biochemistry; 2014 Feb; 53(4):787-95. PubMed ID: 24433134
[TBL] [Abstract][Full Text] [Related]
3. Metformin: clinical use in type 2 diabetes.
Sanchez-Rangel E; Inzucchi SE
Diabetologia; 2017 Sep; 60(9):1586-1593. PubMed ID: 28770321
[TBL] [Abstract][Full Text] [Related]
4. Involvement of glucagon-like peptide-1 in the glucose-lowering effect of metformin.
Bahne E; Hansen M; Brønden A; Sonne DP; Vilsbøll T; Knop FK
Diabetes Obes Metab; 2016 Oct; 18(10):955-61. PubMed ID: 27265206
[TBL] [Abstract][Full Text] [Related]
5. Metformin Prevents Hyperglycemia-Associated, Oxidative Stress-Induced Vascular Endothelial Dysfunction: Essential Role for the Orphan Nuclear Receptor Human Nuclear Receptor 4A1 (Nur77).
Venu VKP; Saifeddine M; Mihara K; Faiza M; Gorobets E; Flewelling AJ; Derksen DJ; Hirota SA; Marei I; Al-Majid D; Motahhary M; Ding H; Triggle CR; Hollenberg MD
Mol Pharmacol; 2021 Nov; 100(5):428-455. PubMed ID: 34452975
[TBL] [Abstract][Full Text] [Related]
6. Metformin--mode of action and clinical implications for diabetes and cancer.
Pernicova I; Korbonits M
Nat Rev Endocrinol; 2014 Mar; 10(3):143-56. PubMed ID: 24393785
[TBL] [Abstract][Full Text] [Related]
7. Action of metformin on glucose transport and glucose transporter GLUT1 and GLUT4 in heart muscle cells from healthy and diabetic rats.
Fischer Y; Thomas J; Rösen P; Kammermeier H
Endocrinology; 1995 Feb; 136(2):412-20. PubMed ID: 7835271
[TBL] [Abstract][Full Text] [Related]
8. Metformin, lipids and atherosclerosis prevention.
Jenkins AJ; Welsh P; Petrie JR
Curr Opin Lipidol; 2018 Aug; 29(4):346-353. PubMed ID: 29878903
[TBL] [Abstract][Full Text] [Related]
9. Role of AMP-activated protein kinase in mechanism of metformin action.
Zhou G; Myers R; Li Y; Chen Y; Shen X; Fenyk-Melody J; Wu M; Ventre J; Doebber T; Fujii N; Musi N; Hirshman MF; Goodyear LJ; Moller DE
J Clin Invest; 2001 Oct; 108(8):1167-74. PubMed ID: 11602624
[TBL] [Abstract][Full Text] [Related]
10. Insights into the action of the pharmaceutical metformin: Targeted inhibition of the gut microbial enzyme agmatinase.
Tassoulas LJ; Wackett LP
iScience; 2024 Feb; 27(2):108900. PubMed ID: 38318350
[TBL] [Abstract][Full Text] [Related]
11. Metformin: from mechanisms of action to therapies.
Foretz M; Guigas B; Bertrand L; Pollak M; Viollet B
Cell Metab; 2014 Dec; 20(6):953-66. PubMed ID: 25456737
[TBL] [Abstract][Full Text] [Related]
12. Lab-on-a-disc agglutination assay for protein detection by optomagnetic readout and optical imaging using nano- and micro-sized magnetic beads.
Uddin R; Burger R; Donolato M; Fock J; Creagh M; Hansen MF; Boisen A
Biosens Bioelectron; 2016 Nov; 85():351-357. PubMed ID: 27183287
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of action of metformin: old or new insights?
Rena G; Pearson ER; Sakamoto K
Diabetologia; 2013 Sep; 56(9):1898-906. PubMed ID: 23835523
[TBL] [Abstract][Full Text] [Related]
14. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
15. A proposal for the locus of metformin's clinical action: potentiation of the activation of pyruvate kinase by fructose-1,6-diphosphate.
McCarty MF
Med Hypotheses; 1999 Feb; 52(2):89-93. PubMed ID: 10340287
[TBL] [Abstract][Full Text] [Related]
16. Current understanding of metformin effect on the control of hyperglycemia in diabetes.
An H; He L
J Endocrinol; 2016 Mar; 228(3):R97-106. PubMed ID: 26743209
[TBL] [Abstract][Full Text] [Related]
17. Erratum: Preparation of Poly(pentafluorophenyl acrylate) Functionalized SiO2 Beads for Protein Purification.
J Vis Exp; 2019 Apr; (146):. PubMed ID: 31038480
[TBL] [Abstract][Full Text] [Related]
18. DEPTOR-related mTOR suppression is involved in metformin's anti-cancer action in human liver cancer cells.
Obara A; Fujita Y; Abudukadier A; Fukushima T; Oguri Y; Ogura M; Harashima S; Hosokawa M; Inagaki N
Biochem Biophys Res Commun; 2015 May; 460(4):1047-52. PubMed ID: 25843797
[TBL] [Abstract][Full Text] [Related]
19. Metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena.
Martin-Castillo B; Vazquez-Martin A; Oliveras-Ferraros C; Menendez JA
Cell Cycle; 2010 Mar; 9(6):1057-64. PubMed ID: 20305377
[TBL] [Abstract][Full Text] [Related]
20. Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo.
Madiraju AK; Qiu Y; Perry RJ; Rahimi Y; Zhang XM; Zhang D; Camporez JG; Cline GW; Butrico GM; Kemp BE; Casals G; Steinberg GR; Vatner DF; Petersen KF; Shulman GI
Nat Med; 2018 Sep; 24(9):1384-1394. PubMed ID: 30038219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
